Literature DB >> 3495094

Effect of radioactive iodine therapy on parotid gland function.

H Maier, H Bihl.   

Abstract

In 37 males and females with thyroid carcinoma, treated with radio-iodine, parotid gland function was investigated before and one week after therapy. 34 subjects remained free of complaints and showed no effect of 131I-therapy on parotid flow rate. Following therapy, all of them showed alterations in the composition of parotid secretion, especially enhanced values for alpha-amylase activity, protein concentration and sodium concentration. Three subjects developed acute parotitis of the obstructive sialadenitis type. In these patients, flow rate was severely reduced. The values for PHI, sodium, alpha-amylase and protein in parotid saliva were markedly elevated. Just as in chronic recurrent parotitis, increased activity of salivary glandular kallikrein in radio-iodine sialadenitis was measured.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3495094

Source DB:  PubMed          Journal:  Acta Otolaryngol        ISSN: 0001-6489            Impact factor:   1.494


  4 in total

Review 1.  Does amifostine have radioprotective effects on salivary glands in high-dose radioactive iodine-treated differentiated thyroid cancer.

Authors:  Chao Ma; Jiawei Xie; Zhongxin Jiang; Guoming Wang; Shuyao Zuo
Journal:  Eur J Nucl Med Mol Imaging       Date:  2010-02-04       Impact factor: 9.236

Review 2.  RETRACTED ARTICLE: Radiation sialadenitis induced by high-dose radioactive iodine therapy.

Authors:  Shin Young Jeong; Jaetae Lee
Journal:  Nucl Med Mol Imaging       Date:  2010-04-21

Review 3.  Clinical Studies of Nonpharmacological Methods to Minimize Salivary Gland Damage after Radioiodine Therapy of Differentiated Thyroid Carcinoma: Systematic Review.

Authors:  Andri Christou; Evridiki Papastavrou; Anastasios Merkouris; Savvas Frangos; Panayiota Tamana; Andreas Charalambous
Journal:  Evid Based Complement Alternat Med       Date:  2016-06-30       Impact factor: 2.629

4.  [Anxiety and depression in patients treated for differentiated thyroid microcarcinoma].

Authors:  Nassim Essabah Haraj; Siham El Aziz; Asma Chadli
Journal:  Pan Afr Med J       Date:  2020-04-20
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.